HeartSciences EBIT Margin 2022-2025 | HSCS
Current and historical EBIT (Earnings Before Interest & Taxes) margin for HeartSciences (HSCS) over the last 10 years. The current EBIT profit margin for HeartSciences as of January 31, 2025 is .
| HeartSciences EBIT Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBIT | EBIT Margin |
| 2024-01-31 | $0.00B | $-0.01B | 0.00% |
| 2023-10-31 | $0.00B | $-0.01B | 0.00% |
| 2023-04-30 | $0.00B | $-0.01B | 0.00% |
| 2023-01-31 | $0.00B | $-0.01B | 0.00% |
| 2022-04-30 | $0.00B | $-0.01B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.004B | $0.000B |
| Heart Test Laboratories, Inc. d/b/a HeartSciences is a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG's clinical utility. Millions of ECGs are performed every week and the Company's objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. HeartSciences has one of the largest libraries of AI-ECG algorithms and is developing AI-ECG solutions to be made available on either a hardware agnostic cloud-based platform or its proprietary MyoVista? wavECG(TM) device, to help identify cardiovascular disease in any care setting worldwide in a manner to best suit different care providers. HeartSciences' first product candidate for FDA clearance, the MyoVista? wavECG(TM), or the MyoVista(R), is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.020B | 52.51 |
| Tempus AI (TEM) | United States | $8.898B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $7.354B | 118.21 |
| Inspire Medical Systems (INSP) | United States | $4.713B | 91.55 |
| IRhythm Technologies (IRTC) | United States | $3.412B | 0.00 |
| Privia Health (PRVA) | United States | $2.848B | 213.46 |
| Enovis (ENOV) | United States | $1.975B | 12.22 |
| Schrodinger (SDGR) | United States | $1.872B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.737B | 0.00 |
| Phreesia (PHR) | United States | $1.467B | 0.00 |
| Omnicell (OMCL) | United States | $1.464B | 31.58 |
| Azenta (AZTA) | United States | $1.204B | 56.04 |
| 10x Genomics (TXG) | United States | $1.011B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.568B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.536B | 0.00 |
| Talkspace (TALK) | United States | $0.517B | 307.00 |
| Veradigm (MDRX) | United States | $0.460B | 0.00 |
| Standard BioTools (LAB) | United States | $0.421B | 0.00 |
| TruBridge (TBRG) | United States | $0.389B | 0.00 |
| Claritev (CTEV) | United States | $0.363B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.277B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.209B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| Pulmonx (LUNG) | United States | $0.194B | 0.00 |
| American Well (AMWL) | United States | $0.114B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.092B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.085B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.082B | 0.00 |
| CareCloud (CCLD) | United States | $0.077B | 3.33 |
| 111 (YI) | China | $0.071B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.059B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Outset Medical (OM) | United States | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |